Global Companion Cancer Diagnostic Testing Market US$ 5 Billion by 2021

Global Companion Cancer Diagnostic Testing Market US$ 5 Billion by 2021

Companion Cancer Diagnostic Testing Market – Global Cancer Diseases Analysis and Forecast 2017-2021, estimates the global companion diagnostic testing market to reach nearly US$ 4.5 Billion in 2020, at a CAGR of 10% from 2017 to 2021 – iHealthcareAnalyst, Inc.

Visit the Companion Cancer Diagnostic Testing Market – Global Cancer Diseases Analysis and Forecast 2017-2021 report at https://www.ihealthcareanalyst.com/report/companion-diagnostics-market/

The emergence of targeted therapies in oncology brings an increased need for companion diagnostic tests. Companion diagnostics are medical devices that help physicians to decide the treatments and effective dosage for patients and which are tailored specifically to the patient. It is an in vitro device, which provides information that is essential for the safe and effective use of a corresponding drug or biological product. The companion diagnostic testing market report estimates the market size (Revenue US$ million – 2014 to 2021) for market segmentation based on indication or disease type (breast cancer, colorectal cancer, gastric cancer, lung cancer, melanoma, etc.), and forecasts growth trends (CAGR% – 2017 to 2021). It also provides the detailed market landscape and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent acquisitions and alliances.

The global companion diagnostic testing market is segmented as:

  1. Indication (Cancer Type)
    • Breast Cancer
    • Colorectal Cancer
    • Gastric Cancer
    • Lung Cancer
    • Melanoma
    • Others (HIV, Thalassemia)
  1. Geography (Region, Country)
    • North America (U.S., Canada)
    • Latin America (Brazil, Mexico, Rest of LA)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Asia Pacific (Japan, China, India, Rest of APAC)
    • Rest of the World
  1. Company Profiles
    • Abbott Laboratories
    • Agendia N.V.
    • Agilent Technologies, Inc.
    • BioGenex Laboratories Inc.
    • bioMérieux SA
    • GE Healthcare
    • Genomic Health, Inc.
    • Hoffmann-La Roche Ltd.
    • Qiagen N.V.
    • Resonance Health Analysis Services Pty Ltd.
    • Siemens Healthcare
    • Thermo Fisher Scientific (Life Technologies Corp.)

About Us

iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.

iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.

Contact Us

iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: [email protected]
Website: https://www.ihealthcareanalyst.com

2017-11-05T10:57:33+00:00 Categories: Press Releases|